piroxantrone has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Au, ICH; Chan, EWY; Cheng, FWT; Cheng, WY; Chui, CSL; Lai, FTT; Li, X; Mak, LY; Wan, EYF; Wong, CKH; Wong, ICK; Yuen, MF | 1 |
1 other study(ies) available for piroxantrone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
Topics: Anthraquinones; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Humans; Liver; Pyrazoles; RNA, Messenger; SARS-CoV-2 | 2022 |